Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 23. Januar 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8769  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 175369  
   
The role of neuroendocrine differentiation in treatment resistance of prostate cancer and intervention strategies.
Front Oncol
Wang B, Zhang Y, Zhang W.
PMID: 41573638 [PubMed]


Assessing digital rectal examination and prostate-specific antigen knowledge: a study of Syrian medical students' knowledge for prostate cancer screening.
BMC Med Educ
Al-Shafie M, Al-Bitar A, Jouby M, Hiba I, Tello MK, Saifo M.
PMID: 41572262 [PubMed - as supplied by publisher]


Accuracy, readability, and understandability of EAU guidelines bot for testicular cancer.
Int Urol Nephrol
Gallo G, Lombardo R, Pagliarulo V, Sequi MB, Coppola LM, Rosato E, Romagnoli M, De Cillis S, Checcucci E, Amparore D, Ragonese M, Foschi N, Santarelli V, Spatafora P, Tema G, Nacchia A, Cicione A, Franco A, Pastore AL, Al Salhi Y, Rocco B, Gacci M, Fiori C, Finazzi Agrò E, Sciarra A, Tubaro A, De Nunzio C, Next-Gen Research Group.
PMID: 41572051 [PubMed - as supplied by publisher]


ReIMAGINE study insights: Can abbreviated bpMRI transform prostate cancer screening?
Eur Radiol
Muglia VF, Verma S.
PMID: 41572046 [PubMed - as supplied by publisher]


Contemporary management of locally advanced prostate cancer: a narrative review and expert perspective.
World J Urol
Kafka M, Heidegger I.
PMID: 41572035 [PubMed - in process]


Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial.
Eur Urol
Kitamura H, Tsukamoto T, Kakehi Y, Mizusawa J, Shibata T, Sasaki K, Tanikawa T, Hashine K, Fujimoto K, Masumori N, Kobayashi T, Habuchi T, Kimura T, Sugimoto M, Takahashi A, Adachi H, Matsui Y, Hatakeyama S, Ito A, Eto M, Nishiyama H, Urologic Oncology Study Group of the Japan Clinical Oncology Group.
PMID: 41571573 [PubMed - as supplied by publisher]


Efficacy and Safety of Immune Checkpoint Blockade in Locally Advanced or Metastatic Penile Cancer: A Systematic Review and Meta-Analysis.
Clin Genitourin Cancer
Noronha MM, de Almeida LFC, Passos PRC, da Silva LFL, Cappellaro AP, Filho VOC, Santana LG, Park CL, Saldanha EF.
PMID: 41571538 [PubMed - as supplied by publisher]


Natural product-mediated autophagy targeting for prostate cancer: A novel potential therapeutic strategy.
Phytomedicine
Zhang M, Zhong J, Yu M, Wang J, Zhang T, Liu M, Zhang P.
PMID: 41571467 [PubMed - as supplied by publisher]


[Therapy-Associated Neuroendocrine Prostate Cancer (tNEPC): A Diagnostic and Therapeutic Challenge in Uro-Oncology with Emerging Clinical Implications].
Aktuelle Urol
von Amsberg G, Hartmann A, Eckstein M, Heidegger I.
PMID: 41571001 [PubMed - as supplied by publisher]


Cyclin D1 and the resistance landscape of HIF2 inhibition in clear-cell renal cell carcinoma: Insights from a mini-review.
Biochem Biophys Res Commun
Zhong Z, Yang A, Wang J, Tian Y, Ma B, Liu X.
PMID: 41570697 [PubMed - as supplied by publisher]


Evaluation of Loss of the Y Chromosome in Peripheral Blood as a Biomarker for Prostate Cancer.
Prostate
Lu J, Lu Y, Kobayashi T, Hachiya T, Wakita H, Jin Y, Tanaka Y, Ikehata Y, Nagata M, Ide H, Horie S.
PMID: 41570183 [PubMed - as supplied by publisher]


Effect of Celecoxib Combined With Low-Dose-Rate Brachytherapy on Long-Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open-Label Controlled Randomized Trial.
Prostate
Nakai Y, Onishi K, Asakawa I, Miyake M, Yamaki K, Isohashi F, Fujimoto K, Tanaka N.
PMID: 41570179 [PubMed - as supplied by publisher]


Pelvic Lymph Node Staging With PSMA PET in Prostate Cancer: Surgical Validation With Implications for Radiotherapy Planning.
Prostate
Ozen A, Sarikaya Z, Gur C, Ozboru D, Canat HL.
PMID: 41570172 [PubMed - as supplied by publisher]


Development and Validation of a Nomogram for Predicting Pathological Upgrading in Men With Biopsy Gleason 3 + 3 Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based Study.
Prostate
Li H, Xiong S, Wang M, Liu M, Wang J, Wang J, Lv Z.
PMID: 41570160 [PubMed - as supplied by publisher]


First-in-class HIF-2α therapy in genitourinary oncology: Belzutifan from von Hippel-Lindau disease to advanced renal cell carcinoma.
Cancer Chemother Pharmacol
Karaman I, Erdem D, Cetin B.
PMID: 41569310 [PubMed - indexed for MEDLINE]


NF-κB (p65, p50), IL-18, and IL-10 as Therapeutic Targets in Prostate Cancer and BPH: Molecular Insights into Inflammation-Driven Pathogenesis.
Asian Pac J Cancer Prev
Dwivedi S, Saini S, - A, Np AK, Bansal A, Sharma RS, Shekhar S, - D, Goel A, Khattri S.
PMID: 41569207 [PubMed - indexed for MEDLINE]


The Radical Prostatectomy Versus Brachytherapy for the Management of Low- and Intermediate-Risk Prostate Cancer: A Meta-Analysis of Observational Studies Focusing on Oncological Outcomes.
Asian Pac J Cancer Prev
Warli SM, Ikram MF, Kadar DD, Siregar GP, Prapiska FF, Laksmi LI, Tala ZZ, Siregar DI, Siregar MIS.
PMID: 41569192 [PubMed - indexed for MEDLINE]


Tumor Morphology as a Risk Factor for Muscle Invasiveness in Newly Diagnosed Bladder Cancer: A Stratified Analysis.
Asian Pac J Cancer Prev
Do NT, Nguyen Tung L, Nguyen Cong D, Do MT.
PMID: 41569182 [PubMed - indexed for MEDLINE]


First look at evaluation of serum angiopoietin-like 4 levels in bladder cancer: A pilot study.
J Physiol Pharmacol
Strojny Z, Kanikowska A, Sikora W, Lewandowska M, Sato M, Strojny M, Zuraszek-Szymanska J, Deja T, Paszynska E, Korybalska K, Breborowicz A, Witowski J, Kanikowska D.
PMID: 41569057 [PubMed - indexed for MEDLINE]


Coriandrum sativum improves prognosis in clear cell renal cell carcinoma by targeting NEK6 to modulate the immune microenvironment: a predictive study based on network pharmacology and multi-omics analysis.
Artif Cells Nanomed Biotechnol
Li J, Zhang Y, Wang X, Zhang P, Xu Z, Huang R, Hu H.
PMID: 41568676 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 175369    Seite 1 von 8769  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1